Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia.
We applied nicotine 21 mg and matching placebo transdermal patches to thirty haloperidol-treated patients with schizophrenia who smoked. Clinical assessments of bradykinesia-rigidity were lower during nicotine patch administration than during placebo patch administration.